Medios AG

XETRA ILM1.DE

Medios AG EBIT Margin for the year ending December 31, 2023: 1.78%

Medios AG EBIT Margin is 1.78% for the year ending December 31, 2023, a -1.37% change year over year. EBIT ratio is the ratio of EBIT to revenue, measuring a company's operating profitability without considering non-operating income or expenses.

Medios AG EBIT Margin for the year ending December 31, 2022 was 1.81%, a 60.13% change year over year.
Medios AG EBIT Margin for the year ending December 31, 2021 was 1.13%, a -26.21% change year over year.
Medios AG EBIT Margin for the year ending December 31, 2020 was 1.53%, a -45.22% change year over year.
Medios AG EBIT Margin for the year ending December 31, 2019 was 2.79%, a 23.33% change year over year.

Key data

Date	EBIT Margin	EPS (Basic)	EPS (Diluted)	Shares (Basic, Weighted)

XETRA: ILM1.DE

Medios AG

CEO	Mr. Matthias Gaertner
IPO Date	Dec. 28, 2007
Location	Germany
Headquarters	Heidestrasse 9
Employees	1,011
Sector	Healthcare
Industries Drugstores & Retail Pharmacies Biotechnology Eyewear Pharmaceuticals

Description

Medios AG, together with its subsidiaries, engages in the wholesale of specialty pharmaceutical drugs in Germany. It operates through Pharmaceutical Supply and Patient-Specific Therapies segments. The Pharmaceutical Supply segment offers products on oncology, neurology, autoimmunology, ophthalmology, infectiology, and hemophilia diseases. The Patient-Specific Therapies segment manufactures medications for patients on behalf of pharmacies; and patient-specific therapies for dispensing individually dosed tablets. The company was founded in 2016 and is based in Berlin, Germany.

Key trends

Past 5 years